Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.

Uccini S, Perotti D, Colarossi C, Stoppacciaro A, Sardella M, Mannarino O, Collini P, Casieri P, Cozzi D, Amoroso L, Spreafico F, Radice P, Dominici C.

Pediatr Blood Cancer. 2008 Sep;51(3):344-8. doi: 10.1002/pbc.21507.

PMID:
18293378
2.
3.

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.

Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B.

Am J Pathol. 2004 Dec;165(6):1943-53.

4.

Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.

Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE.

Pediatr Dev Pathol. 2004 Mar-Apr;7(2):125-37. Epub 2004 Mar 4. Erratum in: Pediatr Dev Pathol. 2004 Sep-Oct;7(5):549.

PMID:
14994125
5.

Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.

Park S, Tomlinson G, Nisen P, Haber DA.

Cancer Res. 1993 Oct 15;53(20):4757-60.

6.

Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor.

Kusafuka T, Miao J, Kuroda S, Udatsu Y, Yoneda A.

Int J Mol Med. 2002 Oct;10(4):395-9.

PMID:
12239584
7.

Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.

Haruta M, Arai Y, Sugawara W, Watanabe N, Honda S, Ohshima J, Soejima H, Nakadate H, Okita H, Hata J, Fukuzawa M, Kaneko Y.

Genes Chromosomes Cancer. 2008 Aug;47(8):712-27. doi: 10.1002/gcc.20572.

PMID:
18464243
8.

Two molecular subgroups of Wilms' tumors with or without WT1 mutations.

Schumacher V, Schuhen S, Sonner S, Weirich A, Leuschner I, Harms D, Licht J, Roberts S, Royer-Pokora B.

Clin Cancer Res. 2003 Jun;9(6):2005-14.

9.

Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Maiti S, Alam R, Amos CI, Huff V.

Cancer Res. 2000 Nov 15;60(22):6288-92.

10.

Small glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) syndrome.

Dahan K, Kamal M, Noël LH, Jeanpierre C, Gubler MC, Brousse N, Mariaud de Serre NP.

Am J Kidney Dis. 2007 Jun;49(6):793-800.

PMID:
17533022
11.

Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.

Satoh Y, Nakagawachi T, Nakadate H, Kaneko Y, Masaki Z, Mukai T, Soejima H.

J Biochem. 2003 Mar;133(3):303-8.

12.

Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Haruta M, Arai Y, Watanabe N, Fujiwara Y, Honda S, Ohshima J, Kasai F, Nakadate H, Horie H, Okita H, Hata J, Fukuzawa M, Kaneko Y.

Cancer Sci. 2012 Jun;103(6):1129-35. doi: 10.1111/j.1349-7006.2012.02269.x. Epub 2012 Apr 19.

13.

[Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].

Stallmach T, Neuhaus TJ, Kösters R, Hailemariam S.

Pathologe. 1998 May;19(3):230-4. German.

PMID:
9648150
14.

Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.

Fukuzawa R, Heathcott RW, More HE, Reeve AE.

J Clin Pathol. 2007 Sep;60(9):1013-6. Epub 2006 Dec 15. Erratum in: J Clin Pathol. 2007 Nov;60(11):1296.

15.

Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.

Shibata R, Takata A, Hashiguchi A, Umezawa A, Yamada T, Hata J.

Pathol Int. 2003 Apr;53(4):214-20.

PMID:
12675764
16.

Recent advances in Wilms tumor genetics.

Dome JS, Coppes MJ.

Curr Opin Pediatr. 2002 Feb;14(1):5-11. Review.

PMID:
11880727
17.

WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.

Cardoso LC, De Souza KR, De O Reis AH, Andrade RC, Britto AC Jr, De Lima MA, Dos Santos AC, De Faria PS, Ferman S, Seuánez HN, Vargas FR.

Oncol Rep. 2013 Jan;29(1):315-20. doi: 10.3892/or.2012.2096. Epub 2012 Oct 19.

PMID:
23117548
18.

WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.

Perotti D, Mondini P, Terenziani M, Spreafico F, Collini P, Fossati-Bellani F, Radice P.

J Pediatr Hematol Oncol. 2005 Apr;27(4):197-201.

PMID:
15838390
19.

Vertical transmission of a mutation in exon 1 of the WT1 gene: lessons for genetic counseling.

Regev M, Kirk R, Mashevich M, Bistritzer Z, Reish O.

Am J Med Genet A. 2008 Sep 15;146A(18):2332-6. doi: 10.1002/ajmg.a.32330.

PMID:
18688870
20.

Canonical WNT signalling determines lineage specificity in Wilms tumour.

Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE.

Oncogene. 2009 Feb 26;28(8):1063-75. doi: 10.1038/onc.2008.455. Epub 2009 Jan 12.

PMID:
19137020

Supplemental Content

Support Center